Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

P&U's Genotropin approved by FDA for adult growth hormone deficiency

Nov. 12, 1997

FDA clears new indication for Zocor

Nov. 11, 1997

Orphan Medical receives approvable letter from FDA for Sucraid

Nov. 11, 1997

PPAR-gamma agonists for endocrine and metabolic disorders

Nov. 11, 1997

Novartis reports protein tyrosine kinase inhibitors for bone disorders

Nov. 10, 1997

Cerebrus uses studies on Redux to design new antiobesity agents

Nov. 10, 1997

Profile of Green Cross's rHSA

Nov. 7, 1997

Cell Genesys reports delivery of erythropoietin gene therapy

Nov. 7, 1997

Neuropeptide Y5 receptor emerges as an important new target in obesity

Nov. 6, 1997

NPS and SmithKline Beecham extend osteoporosis agreement

Nov. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...